{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:42:30Z","timestamp":1793727750318,"version":"4.6.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA232491"],"award-info":[{"award-number":["U01CA232491"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA138313"],"award-info":[{"award-number":["P30 CA138313"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Acute myeloid leukemia (AML) patients present with CD8 exhaustion signatures, and pharmacologic inhibition of checkpoints can have therapeutic benefit. The alarmin IL-33 and its receptor STimulation-2 (ST2) promote activation of tissue-regulatory T cells (T<jats:sub>reg<\/jats:sub> cells) and accelerate malignant progression in solid tumors, but their role in leukemia remains unclear. Here, we show that ST2<jats:sup>+<\/jats:sup> T<jats:sub>reg<\/jats:sub> cells are enriched in bone marrow (BM) of humans and mice with AML and promote CD8<jats:sup>+<\/jats:sup> T cells depletion and exhaustion. ST2 deficiency in T<jats:sub>reg<\/jats:sub> cells restores CD8<jats:sup>+<\/jats:sup> T cell function, decreasing AML growth via retention of ST2<jats:sup>+<\/jats:sup> T<jats:sub>reg<\/jats:sub> cells precursors in lymph nodes. AML-activated ST2<jats:sup>+<\/jats:sup> T<jats:sub>reg<\/jats:sub> cells lack T-bet, IFN-\u03b3 and Bcl-6, and kill intratumoral CD8<jats:sup>+<\/jats:sup> T cells by amplified granzyme B-mediated cytotoxicity compared to non-AML primed T<jats:sub>reg<\/jats:sub> cells. Engineered anti-ST2 antibodies induce ST2<jats:sup>+<\/jats:sup> T<jats:sub>reg<\/jats:sub> cells apoptosis to extend survival in AML models. Together, our findings suggest that ST2 is a potential checkpoint target for AML immunotherapy.<\/jats:p>","DOI":"10.1038\/s41467-025-61647-8","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T09:19:10Z","timestamp":1753089550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["ST2\/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche"],"prefix":"10.1038","volume":"16","author":[{"given":"Hua","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denggang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5770-7187","authenticated-orcid":false,"given":"Santhosh Kumar","family":"Pasupuleti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2206-5720","authenticated-orcid":false,"given":"Baskar","family":"Ramdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9600-326X","authenticated-orcid":false,"given":"Alan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulraouf M.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7545-4619","authenticated-orcid":false,"given":"Ramesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica H.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9435-4720","authenticated-orcid":false,"given":"B. Jacob","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9015-9864","authenticated-orcid":false,"given":"Ed","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2699-626X","authenticated-orcid":false,"given":"Yunlong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0926-0874","authenticated-orcid":false,"given":"Drew","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2822-9420","authenticated-orcid":false,"given":"Suganya","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9028-9458","authenticated-orcid":false,"given":"Stefano","family":"Berto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anilkumar","family":"Gopalakrishnapillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4162-3004","authenticated-orcid":false,"given":"Sonali P.","family":"Barwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6323-5171","authenticated-orcid":false,"given":"Nai-Kong V.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2225-1700","authenticated-orcid":false,"given":"Reuben","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5571-2775","authenticated-orcid":false,"given":"Sophie","family":"Paczesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"61647_CR1","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s41591-020-1089-8","volume":"26","author":"A Burd","year":"2020","unstructured":"Burd, A. et al. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial. Nat. Med. 26, 1852\u20131858 (2020).","journal-title":"Nat. Med."},{"key":"61647_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711\u2013723 (2010).","journal-title":"N. Engl. J. Med."},{"key":"61647_CR3","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443\u20132454 (2012).","journal-title":"N. Engl. J. Med."},{"key":"61647_CR4","doi-asserted-by":"publisher","unstructured":"Knaus, H. A. et al. Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy. JCI Insight 3, https:\/\/doi.org\/10.1172\/jci.insight.120974 (2018).","DOI":"10.1172\/jci.insight.120974"},{"key":"61647_CR5","doi-asserted-by":"publisher","unstructured":"Rutella, S. et al. Signatures of immune dysfunction predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. J. Clin. Investig. https:\/\/doi.org\/10.1172\/JCI159579 (2022).","DOI":"10.1172\/JCI159579"},{"key":"61647_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41591-019-0400-z","volume":"25","author":"C Toffalori","year":"2019","unstructured":"Toffalori, C. et al. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation. Nat. Med. 25, 603\u2013611 (2019).","journal-title":"Nat. Med."},{"key":"61647_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-cancerbio-030419-033428","volume":"4","author":"G Plitas","year":"2020","unstructured":"Plitas, G. & Rudensky, A. Y. Regulatory T cells in cancer. Annu. Rev. Cancer Biol. 4, 459\u2013477 (2020).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"61647_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nri.2016.26","volume":"16","author":"MO Li","year":"2016","unstructured":"Li, M. O. & Rudensky, A. Y. T cell receptor signalling in the control of regulatory T cell differentiation and function. Nat. Rev. Immunol. 16, 220\u2013233 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"61647_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ni.3053","volume":"16","author":"F Yu","year":"2015","unstructured":"Yu, F., Sharma, S., Edwards, J., Feigenbaum, L. & Zhu, J. Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance. Nat. Immunol. 16, 197\u2013206 (2015).","journal-title":"Nat. Immunol."},{"key":"61647_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1074-7613(04)00054-8","volume":"20","author":"U Dittmer","year":"2004","unstructured":"Dittmer, U. et al. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 20, 293\u2013303 (2004).","journal-title":"Immunity"},{"key":"61647_CR11","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1084\/jem.20132577","volume":"211","author":"P Penaloza-MacMaster","year":"2014","unstructured":"Penaloza-MacMaster, P. et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J. Exp. Med. 211, 1905\u20131918 (2014).","journal-title":"J. Exp. Med."},{"key":"61647_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature13577","volume":"513","author":"C Schiering","year":"2014","unstructured":"Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564\u2013568 (2014).","journal-title":"Nature"},{"key":"61647_CR13","doi-asserted-by":"publisher","unstructured":"Yang, J. et al. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease. JCI Insight 4, https:\/\/doi.org\/10.1172\/jci.insight.122014 (2019).","DOI":"10.1172\/jci.insight.122014"},{"key":"61647_CR14","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ni.3799","volume":"18","author":"M Delacher","year":"2017","unstructured":"Delacher, M. et al. Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues. Nat. Immunol. 18, 1160\u20131172 (2017).","journal-title":"Nat. Immunol."},{"key":"61647_CR15","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1016\/j.celrep.2019.10.120","volume":"29","author":"A Li","year":"2019","unstructured":"Li, A. et al. IL-33 signaling alters regulatory T cell diversity in support of tumor development. Cell Rep. 29, 2998\u20133008 e2998 (2019).","journal-title":"Cell Rep."},{"key":"61647_CR16","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1073\/pnas.1815016116","volume":"116","author":"AH Ameri","year":"2019","unstructured":"Ameri, A. H. et al. IL-33\/regulatory T cell axis triggers the development of a tumor-promoting immune environment in chronic inflammation. Proc. Natl. Acad. Sci. USA 116, 2646\u20132651 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61647_CR17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/s41385-019-0176-y","volume":"12","author":"E Pastille","year":"2019","unstructured":"Pastille, E. et al. The IL-33\/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer. Mucosal Immunol. 12, 990\u20131003 (2019).","journal-title":"Mucosal Immunol."},{"key":"61647_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature22360","volume":"546","author":"AG Levine","year":"2017","unstructured":"Levine, A. G. et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature 546, 421\u2013425 (2017).","journal-title":"Nature"},{"key":"61647_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41590-020-0674-9","volume":"21","author":"C Ferreira","year":"2020","unstructured":"Ferreira, C. et al. Type 1 T(reg) cells promote the generation of CD8(+) tissue-resident memory T cells. Nat. Immunol. 21, 766\u2013776 (2020).","journal-title":"Nat. Immunol."},{"key":"61647_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/ni.1731","volume":"10","author":"MA Koch","year":"2009","unstructured":"Koch, M. A. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595\u2013602 (2009).","journal-title":"Nat. Immunol."},{"key":"61647_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1681\/ASN.2015070820","volume":"28","author":"A Nosko","year":"2017","unstructured":"Nosko, A. et al. T-bet enhances regulatory T cell fitness and directs control of Th1 responses in crescentic GN. J. Am. Soc. Nephrol. 28, 185\u2013196 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"61647_CR22","doi-asserted-by":"publisher","unstructured":"Camacho, V. et al. Bone marrow Tregs mediate stromal cell function and support hematopoiesis via IL-10. JCI Insight 5, https:\/\/doi.org\/10.1172\/jci.insight.135681 (2020).","DOI":"10.1172\/jci.insight.135681"},{"key":"61647_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.737880","volume":"9","author":"J Nicholls","year":"2021","unstructured":"Nicholls, J. et al. Bone marrow regulatory T cells are a unique population, supported by niche-specific cytokines and plasmacytoid dendritic cells, and required for chronic graft-versus-host disease control. Front. Cell Dev. Biol. 9, 737880 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"61647_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M. & Alizadeh, A. A. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol. Biol. 1711, 243\u2013259 (2018).","journal-title":"Methods Mol. Biol."},{"key":"61647_CR25","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen, P. et al. Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell 176, 1265\u20131281 e1224 (2019).","journal-title":"Cell"},{"key":"61647_CR26","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.4049\/jimmunol.1103768","volume":"189","author":"G Cheng","year":"2012","unstructured":"Cheng, G. et al. IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells. J. Immunol. 189, 1780\u20131791 (2012).","journal-title":"J. Immunol."},{"key":"61647_CR27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-immunol-032712-095948","volume":"34","author":"M Panduro","year":"2016","unstructured":"Panduro, M., Benoist, C. & Mathis, D. Tissue Tregs. Annu. Rev. Immunol. 34, 609\u2013633 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"61647_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1158\/2159-8290.CD-16-0008","volume":"6","author":"SE Meyer","year":"2016","unstructured":"Meyer, S. E. et al. DNMT3A haploinsufficiency transforms FLT3ITD myeloproliferative disease into a rapid, spontaneous, and fully penetrant acute myeloid leukemia. Cancer Discov. 6, 501\u2013515 (2016).","journal-title":"Cancer Discov."},{"key":"61647_CR29","doi-asserted-by":"publisher","first-page":"308ra160","DOI":"10.1126\/scitranslmed.aab0166","volume":"7","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease. Sci. Transl. Med. 7, 308ra160 (2015).","journal-title":"Sci. Transl. Med."},{"key":"61647_CR30","doi-asserted-by":"publisher","first-page":"e162016","DOI":"10.1172\/jci.insight.162016","volume":"7","author":"B Ramdas","year":"2022","unstructured":"Ramdas, B. et al. Combined heterozygosity of FLT3 ITD, TET2, and DNMT3A results in aggressive leukemia. JCI Insight 7, e162016 (2022).","journal-title":"JCI Insight"},{"key":"61647_CR31","doi-asserted-by":"publisher","first-page":"e163864","DOI":"10.1172\/jci.insight.163864","volume":"8","author":"LR Palam","year":"2023","unstructured":"Palam, L. R. et al. Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathway. JCI Insight 8, e163864 (2023).","journal-title":"JCI Insight"},{"key":"61647_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ccell.2016.05.011","volume":"30","author":"V Stavropoulou","year":"2016","unstructured":"Stavropoulou, V. et al. MLL-AF9 expression in hematopoietic stem cells drives a highly invasive AML expressing EMT-related genes linked to poor outcome. Cancer Cell 30, 43\u201358 (2016).","journal-title":"Cancer Cell"},{"key":"61647_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.molimm.2016.05.019","volume":"75","author":"N Fursov","year":"2016","unstructured":"Fursov, N. et al. Monoclonal antibodies targeting ST2L Domain 1 or Domain 3 differentially modulate IL-33-induced cytokine release by human mast cell and basophilic cell lines. Mol. Immunol. 75, 178\u2013187 (2016).","journal-title":"Mol. Immunol."},{"key":"61647_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/imm.12667","volume":"150","author":"H Tsuzuki","year":"2017","unstructured":"Tsuzuki, H. et al. Functional interleukin-33 receptors are expressed in early progenitor stages of allergy-related granulocytes. Immunology 150, 64\u201373 (2017).","journal-title":"Immunology"},{"key":"61647_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","volume":"8","author":"B Griesenauer","year":"2017","unstructured":"Griesenauer, B. & Paczesny, S. The ST2\/IL-33 axis in immune cells during inflammatory diseases. Front. Immunol. 8, 475 (2017).","journal-title":"Front. Immunol."},{"key":"61647_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","volume":"28","author":"YP Rubtsov","year":"2008","unstructured":"Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546\u2013558 (2008).","journal-title":"Immunity"},{"key":"61647_CR37","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1182\/blood-2011-05-356238","volume":"118","author":"HE Kohrt","year":"2011","unstructured":"Kohrt, H. E. et al. Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation. Blood 118, 5319\u20135329 (2011).","journal-title":"Blood"},{"key":"61647_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02384-y","volume":"18","author":"B Zhou","year":"2020","unstructured":"Zhou, B. et al. WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target. J. Transl. Med. 18, 254 (2020).","journal-title":"J. Transl. Med."},{"key":"61647_CR39","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1073\/pnas.0503726102","volume":"102","author":"CA Klebanoff","year":"2005","unstructured":"Klebanoff, C. A. et al. Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl. Acad. Sci. USA 102, 9571\u20139576 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61647_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.immuni.2019.12.002","volume":"52","author":"M Delacher","year":"2020","unstructured":"Delacher, M. et al. Precursors for nonlymphoid-tissue treg cells reside in secondary lymphoid organs and are programmed by the transcription factor BATF. Immunity 52, 295\u2013312.e211 (2020).","journal-title":"Immunity"},{"key":"61647_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2019.10.032","volume":"469","author":"R Wang","year":"2020","unstructured":"Wang, R. et al. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model. Cancer Lett. 469, 151\u2013161 (2020).","journal-title":"Cancer Lett."},{"key":"61647_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbaexp.2005.01.012","volume":"1728","author":"M Hayakawa","year":"2005","unstructured":"Hayakawa, M. et al. T-helper type 2 cell-specific expression of the ST2 gene is regulated by transcription factor GATA-3. Biochim. Biophys. Acta 1728, 53\u201364 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"61647_CR43","doi-asserted-by":"publisher","first-page":"e0161507","DOI":"10.1371\/journal.pone.0161507","volume":"11","author":"J Siede","year":"2016","unstructured":"Siede, J. et al. IL-33 receptor-expressing regulatory T cells are highly activated, Th2 biased and suppress CD4 T cell proliferation through IL-10 and TGFbeta release. PLoS ONE 11, e0161507 (2016).","journal-title":"PLoS ONE"},{"key":"61647_CR44","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","volume":"169","author":"AE Overacre-Delgoffe","year":"2017","unstructured":"Overacre-Delgoffe, A. E. et al. Interferon-gamma drives T(reg) fragility to promote anti-tumor immunity. Cell 169, 1130\u20131141.e1111 (2017).","journal-title":"Cell"},{"key":"61647_CR45","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.1073\/pnas.1332767100","volume":"100","author":"G Lugo-Villarino","year":"2003","unstructured":"Lugo-Villarino, G., Maldonado-Lopez, R., Possemato, R., Penaranda, C. & Glimcher, L. H. T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc. Natl. Acad. Sci. USA 100, 7749\u20137754 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61647_CR46","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1073\/pnas.1418549112","volume":"112","author":"C Baumann","year":"2015","unstructured":"Baumann, C. et al. T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses. Proc. Natl. Acad. Sci. USA 112, 4056\u20134061 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61647_CR47","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.4049\/jimmunol.1201794","volume":"189","author":"DV Sawant","year":"2012","unstructured":"Sawant, D. V. et al. Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function. J. Immunol. 189, 4759\u20134769 (2012).","journal-title":"J. Immunol."},{"key":"61647_CR48","doi-asserted-by":"publisher","unstructured":"Koh, B. et al. Bcl6 and Blimp1 reciprocally regulate ST2(+) Treg-cell development in the context of allergic airway inflammation. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2020.03.002 (2020).","DOI":"10.1016\/j.jaci.2020.03.002"},{"key":"61647_CR49","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","volume":"27","author":"X Cao","year":"2007","unstructured":"Cao, X. et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635\u2013646 (2007).","journal-title":"Immunity"},{"key":"61647_CR50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cellimm.2014.05.001","volume":"290","author":"HM Lee","year":"2014","unstructured":"Lee, H. M., Kim, K. S. & Kim, J. A comparative study of the effects of inhibitory cytokines on human natural killer cells and the mechanistic features of transforming growth factor-beta. Cell Immunol. 290, 52\u201361 (2014).","journal-title":"Cell Immunol."},{"key":"61647_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0022-1759(00)00329-X","volume":"249","author":"ME Sheehy","year":"2001","unstructured":"Sheehy, M. E., McDermott, A. B., Furlan, S. N., Klenerman, P. & Nixon, D. F. A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J. Immunol. Methods 249, 99\u2013110 (2001).","journal-title":"J. Immunol. Methods"},{"key":"61647_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/hyb.2010.0100","volume":"30","author":"N Fursov","year":"2011","unstructured":"Fursov, N. et al. Generation and characterization of rat anti-mouse ST2L monoclonal antibodies. Hybridoma 30, 153\u2013162 (2011).","journal-title":"Hybridoma"},{"key":"61647_CR53","doi-asserted-by":"publisher","first-page":"6664","DOI":"10.4049\/jimmunol.181.9.6664","volume":"181","author":"L Baudino","year":"2008","unstructured":"Baudino, L. et al. Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions. J. Immunol. 181, 6664\u20136669 (2008).","journal-title":"J. Immunol."},{"key":"61647_CR54","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1158\/2326-6066.CIR-19-0121","volume":"7","author":"L Wang","year":"2019","unstructured":"Wang, L., Hoseini, S. S., Xu, H., Ponomarev, V. & Cheung, N. K. Silencing Fc domains in T cell-engaging bispecific antibodies improves T-cell trafficking and antitumor potency. Cancer Immunol. Res. 7, 2013\u20132024 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"61647_CR55","doi-asserted-by":"publisher","first-page":"eaay4799","DOI":"10.1126\/scitranslmed.aay4799","volume":"12","author":"D Adom","year":"2020","unstructured":"Adom, D. et al. ICOSL(+) plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS\/CD28 antagonist. Sci. Transl. Med. 12, eaay4799 (2020).","journal-title":"Sci. Transl. Med."},{"key":"61647_CR56","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner, H., Weisdorf, D. J. & Bloomfield, C. D. Acute myeloid leukemia. N. Engl. J. Med. 373, 1136\u20131152 (2015).","journal-title":"N. Engl. J. Med."},{"key":"61647_CR57","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/jnci\/djab131","volume":"113","author":"F Islami","year":"2021","unstructured":"Islami, F. et al. Annual report to the Nation on the Status of cancer, part 1: National Cancer Statistics. J. Natl. Cancer Inst. 113, 1648\u20131669 (2021).","journal-title":"J. Natl. Cancer Inst."},{"key":"61647_CR58","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10160","volume":"474","author":"J Fujisaki","year":"2011","unstructured":"Fujisaki, J. et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474, 216\u2013219 (2011).","journal-title":"Nature"},{"key":"61647_CR59","doi-asserted-by":"publisher","first-page":"e136073","DOI":"10.1172\/jci.insight.136073","volume":"5","author":"K Van der Jeught","year":"2020","unstructured":"Van der Jeught, K. et al. ST2 as checkpoint target for colorectal cancer immunotherapy. JCI Insight 5, e136073 (2020).","journal-title":"JCI Insight"},{"key":"61647_CR60","doi-asserted-by":"publisher","first-page":"eaay1813","DOI":"10.1126\/science.aay1813","volume":"369","author":"S Taniguchi","year":"2020","unstructured":"Taniguchi, S. et al. Tumor-initiating cells establish an IL-33-TGF-beta niche signaling loop to promote cancer progression. Science 369, eaay1813 (2020).","journal-title":"Science"},{"key":"61647_CR61","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3892\/ol.2022.13278","volume":"23","author":"C Feng","year":"2022","unstructured":"Feng, C., Kou, L., Yin, P. & Jing, Y. Excessive activation of IL-33\/ST2 in cancer-associated fibroblasts promotes invasion and metastasis in ovarian cancer. Oncol. Lett. 23, 158 (2022).","journal-title":"Oncol. Lett."},{"key":"61647_CR62","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides, A. et al. The complex role of tumor-infiltrating macrophages. Nat. Immunol. 23, 1148\u20131156 (2022).","journal-title":"Nat. Immunol."},{"key":"61647_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.894508","volume":"13","author":"SM Borys","year":"2022","unstructured":"Borys, S. M., Bag, A. K., Brossay, L. & Adeegbe, D. O. The Yin and Yang of targeting KLRG1(+) tregs and effector cells. Front. Immunol. 13, 894508 (2022).","journal-title":"Front. Immunol."},{"key":"61647_CR64","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abk0957","volume":"7","author":"K Itahashi","year":"2022","unstructured":"Itahashi, K. et al. BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors. Sci. Immunol. 7, eabk0957 (2022).","journal-title":"Sci. Immunol."},{"key":"61647_CR65","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41590-023-01697-6","volume":"25","author":"TM Brunner","year":"2024","unstructured":"Brunner, T. M. et al. A type 1 immunity-restricted promoter of the IL-33 receptor gene directs antiviral T-cell responses. Nat. Immunol. 25, 256\u2013267 (2024).","journal-title":"Nat. Immunol."},{"key":"61647_CR66","doi-asserted-by":"publisher","unstructured":"Boroughs, A. C. et al. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function. JCI Insight 5, https:\/\/doi.org\/10.1172\/jci.insight.126194 (2019).","DOI":"10.1172\/jci.insight.126194"},{"key":"61647_CR67","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.4049\/jimmunol.178.6.3637","volume":"178","author":"D Hudrisier","year":"2007","unstructured":"Hudrisier, D., Aucher, A., Puaux, A. L., Bordier, C. & Joly, E. Capture of target cell membrane components via trogocytosis is triggered by a selected set of surface molecules on T or B cells. J. Immunol. 178, 3637\u20133647 (2007).","journal-title":"J. Immunol."},{"key":"61647_CR68","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1073\/pnas.1820388116","volume":"116","author":"M Onda","year":"2019","unstructured":"Onda, M., Kobayashi, K. & Pastan, I. Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity. Proc. Natl. Acad. Sci. USA 116, 4575\u20134582 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61647_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22885-8","volume":"12","author":"Z Amoozgar","year":"2021","unstructured":"Amoozgar, Z. et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat. Commun. 12, 2582 (2021).","journal-title":"Nat. Commun."},{"key":"61647_CR70","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1172\/JCI77347","volume":"125","author":"LF Mager","year":"2015","unstructured":"Mager, L. F. et al. IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. J. Clin. Investig. 125, 2579\u20132591 (2015).","journal-title":"J. Clin. Investig."},{"key":"61647_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.add7705","volume":"16","author":"P Naef","year":"2023","unstructured":"Naef, P. et al. IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways. Sci. Signal. 16, eadd7705 (2023).","journal-title":"Sci. Signal."},{"key":"61647_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.595053","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Interleukin-33 promotes cell survival via p38 MAPK-mediated interleukin-6 gene expression and release in pediatric AML. Front. Immunol. 11, 595053 (2020).","journal-title":"Front. Immunol."},{"key":"61647_CR73","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3324\/haematol.13299","volume":"94","author":"RG Verhaak","year":"2009","unstructured":"Verhaak, R. G. et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica 94, 131\u2013134 (2009).","journal-title":"Haematologica"},{"key":"61647_CR74","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"61647_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33244-6","volume":"13","author":"BJ Huang","year":"2022","unstructured":"Huang, B. J. et al. Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia. Nat. Commun. 13, 5487 (2022).","journal-title":"Nat. Commun."},{"key":"61647_CR76","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3324\/haematol.2017.178442","volume":"103","author":"T Herold","year":"2018","unstructured":"Herold, T. et al. A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia. Haematologica 103, 456\u2013465 (2018).","journal-title":"Haematologica"},{"key":"61647_CR77","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/gcc.20500","volume":"47","author":"DL Stirewalt","year":"2008","unstructured":"Stirewalt, D. L. et al. Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromosomes Cancer 47, 8\u201320 (2008).","journal-title":"Genes Chromosomes Cancer"},{"key":"61647_CR78","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"61647_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"61647_CR80","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.4049\/jimmunol.1202699","volume":"190","author":"RP Sahu","year":"2013","unstructured":"Sahu, R. P. et al. Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists. J. Immunol. 190, 2447\u20132454 (2013).","journal-title":"J. Immunol."},{"key":"61647_CR81","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.4049\/jimmunol.0902685","volume":"184","author":"D Xu","year":"2010","unstructured":"Xu, D. et al. IL-33 exacerbates autoantibody-induced arthritis. J. Immunol. 184, 2620\u20132626 (2010).","journal-title":"J. Immunol."},{"key":"61647_CR82","doi-asserted-by":"publisher","first-page":"83ra41","DOI":"10.1126\/scitranslmed.3001809","volume":"3","author":"KL Hippen","year":"2011","unstructured":"Hippen, K. L. et al. Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci. Transl. Med. 3, 83ra41 (2011).","journal-title":"Sci. Transl. Med."},{"key":"61647_CR83","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1084\/jem.20170041","volume":"214","author":"A Ramadan","year":"2017","unstructured":"Ramadan, A. et al. Specifically differentiated T cell subset promotes tumor immunity over fatal immunity. J. Exp. Med. 214, 3577\u20133596 (2017).","journal-title":"J. Exp. Med."},{"key":"61647_CR84","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.4049\/jimmunol.1800447","volume":"202","author":"B Griesenauer","year":"2019","unstructured":"Griesenauer, B. et al. ST2\/MyD88 deficiency protects mice against acute graft-versus-host disease and spares regulatory T cells. J. Immunol. 202, 3053\u20133064 (2019).","journal-title":"J. Immunol."},{"key":"61647_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"61647_CR86","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/bioinformatics\/bts731","volume":"29","author":"MR Breese","year":"2013","unstructured":"Breese, M. R. & Liu, Y. NGSUtils: a software suite for analyzing and manipulating next-generation sequencing datasets. Bioinformatics 29, 494\u2013496 (2013).","journal-title":"Bioinformatics"},{"key":"61647_CR87","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"61647_CR88","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"61647_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"61647_CR90","doi-asserted-by":"publisher","first-page":"D916","DOI":"10.1093\/nar\/gkaa1087","volume":"49","author":"A Frankish","year":"2021","unstructured":"Frankish, A. et al. Gencode 2021. Nucleic Acids Res. 49, D916\u2013D923 (2021).","journal-title":"Nucleic Acids Res."},{"key":"61647_CR91","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 e3529 (2021).","journal-title":"Cell"},{"key":"61647_CR92","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1101\/gr.192237.115","volume":"25","author":"MS Kowalczyk","year":"2015","unstructured":"Kowalczyk, M. S. et al. Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells. Genome Res. 25, 1860\u20131872 (2015).","journal-title":"Genome Res."},{"key":"61647_CR93","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"PL Germain","year":"2021","unstructured":"Germain, P. L., Lun, A., Garcia Meixide, C., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Research 10, 979 (2021).","journal-title":"F1000Research"},{"key":"61647_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"61647_CR95","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"61647_CR96","doi-asserted-by":"publisher","first-page":"D596","DOI":"10.1093\/nar\/gkab1020","volume":"50","author":"M Li","year":"2022","unstructured":"Li, M. et al. DISCO: a database of deeply integrated human single-cell omics data. Nucleic Acids Res. 50, D596\u2013D602 (2022).","journal-title":"Nucleic Acids Res."},{"key":"61647_CR97","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41586-020-2850-3","volume":"587","author":"S Li","year":"2020","unstructured":"Li, S. et al. Cancer immunotherapy via targeted TGF-beta signalling blockade in T(H) cells. Nature 587, 121\u2013125 (2020).","journal-title":"Nature"},{"key":"61647_CR98","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s43587-022-00241-9","volume":"2","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-epsilon4 in female patients with Alzheimer\u2019s disease. Nat. Aging 2, 616\u2013634 (2022).","journal-title":"Nat. Aging"},{"key":"61647_CR99","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18, e3000410 (2020).","journal-title":"PLoS Biol."},{"key":"61647_CR100","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/ilar.43.4.244","volume":"43","author":"MF Festing","year":"2002","unstructured":"Festing, M. F. & Altman, D. G. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J. 43, 244\u2013258 (2002).","journal-title":"ILAR J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61647-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61647-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61647-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:59:38Z","timestamp":1757253578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61647-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61647"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61647-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"1 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.-K.V.C. reports receiving commercial research grants from Y-mAbs Therapeutics and Abpro-Labs Inc., holding ownership interest\/equity in Y-mAbs Therapeutics Inc., holding ownership interest\/equity in Abpro-Labs, and owning stock options in Eureka Therapeutics. N.-K.V.C. is the inventor and owner of issued patents licensed by Memorial Sloan Kettering Cancer Center (MSKCC) to Y-mAbs Therapeutics, Biotec Pharmacon, and Abpro-labs. Both MSKCC and N.-K.V.C. have financial interests in Y-mAbs. N.-K.V.C. is an advisory board member for Abpro-Labs and Eureka Therapeutics. Otherwise, the authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6580"}}